Stock Themes
Baskets long-term investors actually talk about — with metrics & a 5-year forecast.
Magnificent SevenBig Chip — SemiconductorsUndervaluedGrowthTop Dividend StocksRecession-ProofReal Estate (REITs)Best HealthcareBest Oil & Energy
Magnificent Seven
- The seven mega-cap technology companies — Apple, Microsoft, Alphabet, Amazon, Nvidia, Meta, and Tesla — that together drive a large share of the entire S&P 500's return.
- If you own an index fund you already own a lot of these, so knowing them helps you understand what's really moving your portfolio.
- Huge cash flows and wide moats, but real concentration risk — when these few names fall, the whole market tends to follow.
| Stock | Price | P/E | ROE | Rev Growth | 5-Yr Forecast |
|---|---|---|---|---|---|
| AAPLApple Inc. | $294.30 | 35.2x | 146.7% | 12.8% | 22–31%/yr |
| MSFTMicrosoft Corporation | $373.94 | 22.1x | 33.1% | 17.9% | 22–32%/yr |
| GOOGLAlphabet Inc. | $346.13 | 26.2x | 39.0% | 17.4% | 27–38%/yr |
| AMZNAmazon.com, Inc. | $234.11 | 28x | 23.3% | 14.2% | 27–38%/yr |
| NVDANVIDIA Corporation | $200.04 | 30.6x | 111.7% | 70.7% | 27–38%/yr |
| METAMeta Platforms, Inc. | $562.20 | 20.2x | 33.2% | 26.2% | 1–10%/yr |
| TSLATesla, Inc. | $381.61 | 110x | 4.8% | 2.3% | -15–-8%/yr |
Big Chip — Semiconductors
- The companies that design and manufacture the chips behind AI, phones, cars, and data centers.
- A long-term, pick-and-shovel way to own the growth of technology broadly instead of betting on a single end-product.
- Powerful secular demand, but the industry is cyclical — expect boom-and-bust swings around supply and demand.
| Stock | Price | P/E | ROE | Rev Growth | 5-Yr Forecast |
|---|---|---|---|---|---|
| NVDANVIDIA Corporation | $200.04 | 30.6x | 111.7% | 70.7% | 27–38%/yr |
| AVGOBroadcom Inc. | $380.15 | 61.7x | 36.4% | 32.3% | 27–38%/yr |
| AMDAdvanced Micro Devices, Inc. | $519.85 | 169.2x | 8.1% | 35.0% | 27–38%/yr |
| QCOMQualcomm | $204.13 | 22x | 40.2% | 5.2% | -12–-5%/yr |
| TXNTexas Instruments | $304.36 | 52.4x | 32.5% | 14.9% | 5–13%/yr |
| MUMicron Technology | $1051.77 | 50.3x | 40.8% | 85.5% | 27–38%/yr |
| AMATApplied Materials | $585.88 | 55.6x | 39.8% | 3.3% | 22–32%/yr |
Undervalued
Auto-updated- Companies trading at low earnings multiples relative to their profitability — potential bargains the market may be overlooking.
- Value investing is a long-term bet that price eventually catches up to fundamentals; it rewards patience.
- Beware “value traps” — cheap can stay cheap, so this list pairs a low P/E with real quality (healthy ROE and positive margins).
| Stock | Price | P/E | ROE | Rev Growth | 5-Yr Forecast |
|---|---|---|---|---|---|
| UHSUniversal Health Services | $145.85 | 5.7x | 21.0% | 10.4% | 27–37%/yr |
| EXEExpand Energy | $88.73 | 6.5x | 17.4% | 170.6% | -15–-8%/yr |
| ACGLArch Capital Group | $93.71 | 6.6x | 20.5% | 7.8% | 26–36%/yr |
| EGEverest Group | $343.56 | 6.8x | 13.3% | -0.6% | 27–38%/yr |
| SYFSynchrony Financial | $75.04 | 7.1x | 21.4% | 20.5% | 25–35%/yr |
| PYPLPayPal | $41.70 | 7.3x | 25.1% | 5.8% | 13–22%/yr |
| FISFidelity National Information Services | $38.03 | 7.4x | 18.4% | 12.2% | 27–38%/yr |
| TAT&T | $22.81 | 7.4x | 19.7% | 2.9% | 27–38%/yr |
Growth
Auto-updated- Companies growing revenue quickly and reinvesting for the future rather than paying large dividends.
- Compounding revenue over many years can drive outsized long-term returns.
- The risk is overpaying — valuations are high, so the growth has to actually show up to justify the price.
| Stock | Price | P/E | ROE | Rev Growth | 5-Yr Forecast |
|---|---|---|---|---|---|
| STTState Street Corporation | $173.73 | 15.7x | 11.1% | 181.2% | 5–14%/yr |
| EXEExpand Energy | $88.73 | 6.5x | 17.4% | 170.6% | -15–-8%/yr |
| JPMJPMorgan Chase & Co. | $334.14 | 15.2x | 16.3% | 109.0% | -3–4%/yr |
| BACBank of America | $57.91 | 12.9x | 10.5% | 99.4% | 12–21%/yr |
| CCitigroup | $144.97 | 15.3x | 7.5% | 99.2% | 19–29%/yr |
| MTBM&T Bank | $231.24 | 11.5x | 10.3% | 86.2% | 13–22%/yr |
| MUMicron Technology | $1051.77 | 50.3x | 40.8% | 85.5% | 27–38%/yr |
| USBU.S. Bancorp | $60.05 | 11.7x | 12.2% | 84.1% | 10–19%/yr |
Top Dividend Stocks
Auto-updated- Companies that pay you a slice of their profits in cash every year — income you receive without ever selling a share.
- For long-term investors, reinvested dividends have historically driven a large share of the stock market's total return.
- Watch for “yield traps”: an unusually high yield can signal a struggling business, so this list favours large, profitable payers. The Div Yield column is each stock's annual income return.
| Stock | Price | Div Yield | P/E | ROE | Rev Growth | 5-Yr Forecast |
|---|---|---|---|---|---|---|
| UPSUnited Parcel Service | $105.83 | 6.6% | 17.1x | 33.0% | -2.9% | -15–-8%/yr |
| PFEPfizer | $24.72 | 6.6% | 18.8x | 8.4% | 1.4% | -11–-3%/yr |
| VICIVici Properties | $26.62 | 6.2% | 9.4x | 11.2% | 4.1% | 10–18%/yr |
| MOAltria | $71.61 | 6.1% | 14.8x | 149.7% | -1.1% | -15–-8%/yr |
| VZVerizon | $46.73 | 5.9% | 11.3x | 16.7% | 2.9% | -8–-1%/yr |
| CMCSAComcast | $22.80 | 5.5% | 4.3x | 19.8% | 1.4% | 18–27%/yr |
| ORealty Income | $61.53 | 5.2% | 51.2x | 2.9% | 9.8% | 3–11%/yr |
| PRUPrudential Financial | $108.48 | 5.2% | 10.9x | 10.9% | 3.9% | 27–38%/yr |
| KMBKimberly-Clark | $103.95 | 5.0% | 16.2x | 143.6% | -16.2% | -15–-8%/yr |
| OKEOneok | $88.06 | 4.9% | 15.6x | 15.9% | -14.7% | 3–11%/yr |
Recession-Proof
- Businesses selling what people buy in good times and bad — food, drinks, household staples, and basic healthcare.
- Their earnings hold up better in downturns, so they tend to fall less than the market when the economy weakens.
- The trade-off is slower growth in boom times — these are portfolio ballast, not rockets.
| Stock | Price | P/E | ROE | Rev Growth | 5-Yr Forecast |
|---|---|---|---|---|---|
| PGThe Procter & Gamble Company | $150.86 | 21.1x | 31.2% | 3.3% | 3–11%/yr |
| KOThe Coca-Cola Company | $80.31 | 25.4x | 43.6% | 5.1% | 20–30%/yr |
| PEPPepsiCo, Inc. | $142.05 | 22.2x | 43.9% | 4.3% | -12–-5%/yr |
| WMTWalmart | $119.42 | 41.8x | 23.9% | 5.9% | 15–24%/yr |
| COSTCostco Wholesale Corporation | $957.68 | 48.3x | 28.3% | 9.2% | 6–15%/yr |
| MCDMcDonald's | $271.66 | 22.3x | 95.1% | 6.8% | 1–9%/yr |
| JNJJohnson & Johnson | $239.08 | 27.4x | 26.3% | 7.9% | -9–-2%/yr |
| MDLZMondelez International | $61.06 | 29.6x | 10.1% | 7.8% | -15–-8%/yr |
| CLColgate-Palmolive | $91.43 | 35.3x | 475.1% | 4.3% | -15–-8%/yr |
| WMWaste Management | $218.84 | 31.2x | 28.9% | 10.9% | -2–6%/yr |
Real Estate (REITs)
- REITs own income-producing property — data centers, warehouses, cell towers, apartments, and malls — and must pay out most of their profits as dividends.
- A way to earn real-estate income without being a landlord, usually with above-average dividend yields.
- Interest-rate sensitive: higher rates raise their borrowing costs and make their yields less competitive.
| Stock | Price | P/E | ROE | Rev Growth | 5-Yr Forecast |
|---|---|---|---|---|---|
| AMTAmerican Tower | $179.38 | 28.7x | 78.2% | 6.3% | 27–38%/yr |
| PLDPrologis | $145.25 | 37.3x | 7.0% | 6.7% | -7–1%/yr |
| EQIXEquinix | $1115.93 | 75.3x | 10.0% | 6.7% | 27–38%/yr |
| WELLWelltower | $217.67 | 109.2x | 3.5% | 37.5% | 9–18%/yr |
| DLRDigital Realty | $195.00 | 49.2x | 6.0% | 12.6% | 27–38%/yr |
| PSAPublic Storage | $321.29 | 29.6x | 20.5% | 2.9% | -9–-2%/yr |
| ORealty Income | $61.53 | 51.2x | 2.9% | 9.8% | 3–11%/yr |
| SPGSimon Property Group | $216.74 | 15x | 126.3% | 10.9% | 27–38%/yr |
| CCICrown Castle | $84.33 | 34.8x | 21.0% | -29.6% | -15–-8%/yr |
| VICIVici Properties | $26.62 | 9.4x | 11.2% | 4.1% | 10–18%/yr |
Best Healthcare
- Drugmakers, insurers, and device makers serving demand that doesn't disappear in a recession.
- An aging population and steady medical innovation give the sector a long-term tailwind.
- Watch drug-pricing and policy risk, plus patent expirations that can dent any single company.
| Stock | Price | P/E | ROE | Rev Growth | 5-Yr Forecast |
|---|---|---|---|---|---|
| LLYLilly (Eli) | $1107.08 | 41.5x | 101.3% | 47.4% | 27–38%/yr |
| UNHUnitedHealth Group Incorporated | $409.25 | 30.9x | 12.4% | 9.7% | -15–-8%/yr |
| JNJJohnson & Johnson | $239.08 | 27.4x | 26.3% | 7.9% | -9–-2%/yr |
| MRKMerck & Co. | $119.60 | 33x | 17.9% | 2.9% | -15–-8%/yr |
| ABBVAbbVie | $234.76 | 113.2x | 95.6% | 9.5% | -15–-8%/yr |
| TMOThermo Fisher Scientific | $469.35 | 25.7x | 13.2% | 5.4% | 1–9%/yr |
| ABTAbbott Laboratories | $90.53 | 25.1x | 12.2% | 6.6% | -15–-8%/yr |
| AMGNAmgen | $347.01 | 24.2x | 89.4% | 9.1% | 24–34%/yr |
| PFEPfizer | $24.72 | 18.8x | 8.4% | 1.4% | -11–-3%/yr |
| ISRGIntuitive Surgical | $403.18 | 48.2x | 17.0% | 21.4% | 14–23%/yr |
Best Oil & Energy
- Companies that find, produce, refine, and transport the oil and gas still powering the global economy.
- Often strong dividend payers and a useful hedge against inflation and energy-price spikes.
- Cyclical and volatile — profits swing with commodity prices, and the long-term energy transition is a real risk.
| Stock | Price | P/E | ROE | Rev Growth | 5-Yr Forecast |
|---|---|---|---|---|---|
| XOMExxon Mobil Corporation | $139.73 | 22.7x | 9.8% | -4.1% | -15–-8%/yr |
| CVXChevron Corporation | $175.98 | 31.7x | 6.2% | -3.6% | -15–-8%/yr |
| COPConocoPhillips | $109.97 | 18.2x | 11.3% | 1.4% | -15–-8%/yr |
| EOGEOG Resources | $134.90 | 13x | 18.3% | 2.7% | -11–-4%/yr |
| SLBSchlumberger | $47.79 | 21.5x | 13.6% | -0.4% | -15–-8%/yr |
| PSXPhillips 66 | $170.34 | 16.5x | 14.7% | -2.4% | 27–38%/yr |
| MPCMarathon Petroleum | $248.52 | 15.5x | 27.3% | -0.9% | 27–38%/yr |
| OXYOccidental Petroleum | $52.23 | 11x | 12.9% | -8.0% | 27–38%/yr |
| WMBWilliams Companies | $75.79 | 33.2x | 22.0% | 10.7% | 15–24%/yr |
| KMIKinder Morgan | $32.54 | 21.8x | 10.7% | 13.1% | 21–31%/yr |
Educational stock baskets, not investment advice or a recommendation to buy, hold, or sell any security. The 5-year forecast is an illustrative projection (it grows current earnings by recent growth and applies a steady-to-compressed P/E), not a prediction. Do your own research and consult a licensed professional.